Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

0.0%

0 terminated out of 20 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

30%

6 trials in Phase 3/4

Results Transparency

47%

8 of 17 completed with results

Key Signals

8 with results100% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (9)
P 1 (1)
P 3 (6)

Trial Status

Completed17
Recruiting2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT07093541UnknownPrimary

Expanded Access Program for Treatment With Ecopipam for Tourette's Disorder

NCT06408662Not ApplicableRecruiting

Remote Delivery of a Mindfulness-based Intervention for Tics

NCT05499741Not ApplicableRecruitingPrimary

Forehead Temperature-Regulating Therapy for Insomnia in Adults With Tourette's Disorder

NCT03508245Not ApplicableCompletedPrimary

Investigating Circadian Rhythms in Youth With Persistent Tic Disorders

NCT01177774Completed

Assessment of Children With Tic Onset in the Past 6 Months

NCT03916055Not ApplicableCompletedPrimary

Internet-delivered Behaviour Therapy for Children and Adolescents With Tourette's Disorder

NCT01418339Phase 3CompletedPrimary

Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

NCT01416441Phase 3CompletedPrimary

Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

NCT01418352Phase 3CompletedPrimary

Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)

NCT03042507Not ApplicableCompleted

Psychosocial Intervention for Young Children With Chronic Tics

NCT01795105CompletedPrimary

ABF Tourette's Disorder Post Marketing Surveillance Study

NCT02864589Not ApplicableCompletedPrimary

Internet-based Behaviour Therapy for Tourette's Disorder and Chronic Tic Disorder

NCT01585207Phase 1CompletedPrimary

Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder

NCT02413216Not ApplicableCompletedPrimary

TicHelper: A Computerized Comprehensive Behavioral Intervention for Tics (CBIT)

NCT01727713Phase 3CompletedPrimary

Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

NCT01727700Phase 3CompletedPrimary

Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

NCT02316145Not ApplicableCompleted

Internet-based Coaching for Young Adults With Neuropsychiatric Disorders

NCT01315327Not ApplicableCompletedPrimary

Omega-3 Fatty Acids in Tourette's Disorder

NCT00706589Phase 3Completed

Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder

NCT00579267Completed

Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)

Showing all 20 trials

Research Network

Activity Timeline